Globe Roche Logo

Infographic: Understanding the role of HPV in cervical cancer

Human papillomavirus is responsible for 99 percent of all cervical cancer.

Two specific types, HPV 16 and HPV18, account for 70 percent of these cases.1,2

In ATHENA, the largest-ever study of cervical cancer screening practices, more than 47,000 women were tested for high-risk HPV types using the cobas® HPV Test. The study proved that HPV screening was more effective than Pap tests in both detecting and predicting high-grade cervical disease.

Roche is committed to helping change the standard of HPV screening to give women everywhere the best chance to prevent cervical cancer.